New pyrrolopyrimidin-6-yl benzenesulfonamides: Potent A2B adenosine receptor antagonists
- 15 July 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (14) , 3642-3645
- https://doi.org/10.1016/j.bmcl.2006.04.074
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Adenosine-Activated Mast Cells Induce IgE Synthesis by B Lymphocytes: An A2B-Mediated Process Involving Th2 Cytokines IL-4 and IL-13 with Implications for AsthmaThe Journal of Immunology, 2004
- Adenosine: an endogenous regulator of innate immunityTrends in Immunology, 2004
- Adenosine mediates IL-13–induced inflammation and remodeling in the lung and interacts in an IL-13–adenosine amplification pathwayJournal of Clinical Investigation, 2003
- The case for a role for adenosine in asthma: almost convincing?Current Opinion in Pharmacology, 2003
- Immunological characterization of A2B adenosine receptors in human mast cellsDrug Development Research, 2003
- Induction of interleukin 8 release from the HMC-1 mast cell line: Synergy between stem cell factor and activators of the adenosine A2b receptorBiochemical Pharmacology, 2002
- Adenosine A2B‐receptor‐mediated cyclic AMP accumulation in primary rat astrocytesBritish Journal of Pharmacology, 1994
- Adenosine in Bronchoalveolar Lavage Fluid in AsthmaAmerican Review of Respiratory Disease, 1993
- Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.Proceedings of the National Academy of Sciences, 1992
- Agonist activity of 2- and 5′-substituted adenosine analogs and their N6-cycloalkyl derivatives at A1− and A2−adenosine receptors coupled to adenylate cyclaseBiochemical Pharmacology, 1992